The single dominant fact is the Roth Principal Investments $25,000,000 equity line, effective and commenced 2026-07-14, priced at VWAP less a fixed 3.0%/5.0% discount with a $0.50 threshold price — a floating-price mechanism against a float of ~15.0M shares and an $9.0M market cap. The company's own Proposal No. 5 dilution table concedes 41,666,666 shares at $0.60 (73.4% of post-issuance outstanding) and 31,250,000 at $0.80. With the stock at $0.5961, the facility is worth roughly 2.8x the entire current float in new shares. The 3,004,114-share Exchange Cap (19.99%) is the only near-term brake, and management has expressly placed a proposal before shareholders to remove it, warning it would permit 'a substantially greater number of shares at a lower price per share, resulting in materially greater dilution.' Recent issuance activity is severe and continuous: 4,821,624 ATM shares sold in H1 2026 alone, with shares outstanding up from 6,171,040 (2025-08-08) to 15,064,476 (2026-08-07) — a 144% twelve-month expansion. Offsetting factors that keep this at 9 rather than 10: there are zero convertible notes and zero convertible preferred outstanding, the ATM is nearly exhausted ($670K remaining), all 7.78M warrants are deeply out of the money (lowest strike $1.25 vs $0.5961 — over 2x above market) with no reset or anti-dilution repricing disclosed, and the ELOC is company-optional rather than holder-triggered. The warrant overhang is therefore near-zero risk today; the score is driven almost entirely by the ELOC and the demonstrated 144% issuance cadence.